Vaccines

07 Oct 2010 Synthetic Genomics Inc. and J. Craig Venter Institute Form New Company, Synthetic Genomics Vaccines Inc. (SGVI), to Develop Next Generation Vaccines
07 Oct 2010 Vical to Manufacture DNA Vaccines for Advanced Development by HIV Consortium
05 Oct 2010 Immunovaccine and IRX Therapeutics Collaborate on Cancer Immunotherapies
05 Oct 2010 CureVac presents convincing data from the first ever Phase I/IIa clinical study with a mRNA based vaccine
05 Oct 2010 Liquidia Technologies Initiates Phase 1 Trial of Lead Vaccine Candidate
04 Oct 2010 Dynavax's HEPLISAV Demonstrates Superior Seroprotection in Diabetics Compared to Engerix-B
04 Oct 2010 Celldex Therapeutics Presents Safety and Immunogenicity Data on CDX-1401 at the International Society of Biological Therapy of Cancer Meeting
30 Sep 2010 Circassia Initiates Phase II Trials of Novel Grass and Ragweed Allergy Therapies and Advances Phase III Plans for cat Allergy T-Cell Vaccine
30 Sep 2010 GSK provides update on Herpevac trial for women evaluating Simplirix (Herpes Simplex Vaccine)
28 Sep 2010 Sanofi Pasteur (SASY.PA) Acquires VaxDesign for $60 Million
28 Sep 2010 Dynavax's Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue
28 Sep 2010 Inovio Pharmaceuticals’ HIV DNA Vaccine/Electroporation Delivery Technology Selected for NIH-Sponsored U.S. Army Human Clinical Trial
24 Sep 2010 GSK EU regulatory update on Pandemrix
23 Sep 2010 Dynavax Begins Phase 1b Study for Universal Flu Vaccine
23 Sep 2010 Vaxonco’s EP1300 Epitope-Based DNA Vaccine for Malaria Delivered by Ichor’s TriGrid Electoporation Enters Phase I Trial
22 Sep 2010 Aeras and Crucell Announce Phase II Clinical Trial Start in Kenya
21 Sep 2010 immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio
21 Sep 2010 Inovio Completes Enrollment of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation
17 Sep 2010 Immune Network Ltd. (IMMFF) Announces Intent to Acquire Oral Vaccine Technology Platform from Immunitor
17 Sep 2010 CytoGenix, Inc. Initiates Ferret Testing Expecting Positive Results for Avian Flu Vaccine Study
16 Sep 2010 LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
16 Sep 2010 ImmunoCellular Therapeutics Selects Averion International Corp. to Conduct Phase II Glioblastoma Study
15 Sep 2010 Immune Targeting Systems (ITS) Ltd. Announces First Patient Treated in Phase I Trial of Synthetic Universal Influenza Vaccine
14 Sep 2010 CytoGenix, Inc. Announces Positive Results from DNA Vaccine Study for Avian Flu
13 Sep 2010 Stealt Peptides Inc. Announces Clinical Phase I Results With Bendavia Demonstrating Safety And Tolerability With Highly Predictable Pharmacokinetics

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top